COCCO, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 551
NA - Nord America 528
AS - Asia 344
SA - Sud America 33
AF - Africa 3
Totale 1.459
Nazione #
US - Stati Uniti d'America 521
RU - Federazione Russa 224
CN - Cina 141
GB - Regno Unito 140
SG - Singapore 129
SE - Svezia 53
FR - Francia 30
BR - Brasile 28
HK - Hong Kong 28
DE - Germania 26
IE - Irlanda 25
FI - Finlandia 19
VN - Vietnam 14
IT - Italia 13
KR - Corea 13
BD - Bangladesh 7
UA - Ucraina 7
CA - Canada 4
IN - India 4
BE - Belgio 3
JP - Giappone 3
PL - Polonia 3
AR - Argentina 2
AT - Austria 2
EC - Ecuador 2
ES - Italia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CO - Colombia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
MZ - Mozambico 1
NL - Olanda 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 1.459
Città #
Southend 108
Chandler 83
Moscow 81
Singapore 67
Jacksonville 56
Houston 47
Ashburn 39
Ann Arbor 35
Dallas 29
Beijing 28
Hong Kong 28
Dublin 25
Woodbridge 25
Lancaster 12
Lawrence 11
Princeton 11
The Dalles 11
Jinan 9
Nanjing 9
Seoul 9
Wilmington 9
Columbus 7
Hebei 7
Helsinki 7
Redondo Beach 7
Tianjin 7
Boardman 6
Detroit 6
Ho Chi Minh City 6
Munich 6
Nanchang 6
New York 6
Santa Clara 6
Atlanta 5
Jiaxing 5
Rio de Janeiro 5
Verona 5
Buffalo 4
Hanoi 4
Los Angeles 4
São Paulo 4
Taiyuan 4
Brussels 3
Cascia 3
Chennai 3
Dearborn 3
Guangzhou 3
Leipzig 3
Phoenix 3
Tokyo 3
Zhengzhou 3
Brooklyn 2
Chicago 2
Falkenstein 2
Fuzhou 2
Haikou 2
Hangzhou 2
London 2
Naples 2
North Bergen 2
Nuremberg 2
Poplar 2
Seattle 2
Shenyang 2
Toronto 2
Warsaw 2
Amman 1
Anápolis 1
Aquiraz 1
Auburn Hills 1
Augusta 1
Bilgi 1
Boston 1
Brazzaville 1
Burgas 1
Bình An 1
Bắc Ninh 1
Calgary 1
Cambé 1
Changsha 1
Chaoyang 1
City of London 1
Clearwater 1
Cleveland 1
Colatina 1
Cormons 1
Cotia 1
Council Bluffs 1
Cuddalore 1
Curitiba 1
Denver 1
Dhaka 1
Dubai 1
Edinburgh 1
Elk Grove Village 1
Esteio 1
Fairfield 1
Fighiera 1
Frankfurt am Main 1
Fushan 1
Totale 940
Nome #
Follicle-Stimulating Hormone and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis of Prostate Cancer and Subsequent Cluster Selection of the Patient Population Undergoing Standard Radical Prostatectomy 166
Investigative clinical study on prostate cancer part VIII: prolactin hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy. 148
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 146
Choosing wisely: la lista del gruppo di studio Endocrinologia e Malattie del Metabolismo della Società Italiana di Patologia Clinica e Medicina di Laboratorio 140
Investigative clinical study on prostate cancer Part V: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 137
Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 133
DEFINITION OF UPPER REFERENCE LIMIT FOR THYROID PEROXIDASE AUTOANTIBODIES ACCORDING TO NACB GUIDELINES: COMPARISON OF SEVEN DIFFERENT AUTOMATED METHODS. Part B (in : Reference ranges, standardization and decision levels) 126
DEFINITION OF UPPER REFERENCE LIMIT FOR THYROID PEROXIDASE AUTOANTIBODIES ACCORDING TO NACB GUIDELINES: COMPARISON OF FIVE DIFFERENT AUTOMATED METHODS. PART A (in Reference ranges, standardization and decision levels) 125
Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy 120
Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population. 119
Role of CA 15-3 to guide therapy in metastatic breast cancer [Il ruolo di CA 15-3 nel monitoraggio della terapia nel carcinoma mammario metastatico] 112
Totale 1.472
Categoria #
all - tutte 5.241
article - articoli 4.373
book - libri 0
conference - conferenze 868
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 10 2 5 0 1 9 3
2021/2022118 12 36 0 23 0 7 2 6 2 2 4 24
2022/2023196 20 17 23 26 20 41 3 17 16 1 8 4
2023/202497 4 14 9 5 16 15 1 7 0 11 10 5
2024/2025194 9 18 15 33 5 13 2 4 24 11 18 42
2025/2026460 54 23 40 116 188 39 0 0 0 0 0 0
Totale 1.472